HEADLINES

Caribbean Island Launches Probe Into Billionaire Pay-Pal Co-Founder Peter Thiel’s   Backed Offshore Herpes Vaccine Research

Get our headlines on WHATSAPP: 1) Save +1 (869) 665-9125 to your contact list. 2) Send a WhatsApp message to that number so we can add you 3) Send your news, photos/videos to times.caribbean@gmail.com

Pay-Pal Co-Founder and Eccentric Billionaire Peter Thiel

(Washington, DC ) The Small Caribbean Twin-Island Federation of St.Kitts-Nevis has launched a full investigation into Herpes Vacine Trials alleged to have taken place on the beautiful idyllic St.Kitts in 2016. In a statement issued on Thursday the government declared that they had no knowledge of the Trials and that absolutely no approval was sought of the Island’s Medical Board, Ministry of Health or any similar authority , for the Trials.

The vaccine research has sparked controversy because the lead investigator, a professor with Southern Illinois University, and the U.S. company he co-founded did not rely on traditional U.S. safety oversight while testing the vaccine last year on mostly American participants on the Caribbean island of St. Kitts.

The trial received financial backing from from eccentric tech billionaire and  Donald Trump supporter Peter Thiel.

The American  Food and Drug Administration nor a safety panel known as an institutional review board, or an “IRB,” monitored the testing on the 20 American human subjects. The  researchers also did not officially seek permission from any of the Caribbean Islands’ medical or government authorities  to test the vaccine, which took place from April to August 2016.

“The Ministry of Health states categorically that neither the Cabinet, the Ministry of Health, the office of Chief Medical Officer (CMO) nor the St. Kitts and Nevis Medical Board has ever been approached on this project,” said the government press release sent out Wednesday night. “By extension, none of these agencies has approved such a venture.”

U.S. researchers are increasingly going offshore to developing countries to conduct clinical trials, citing rising domestic costs. But in order to approve the drug for the U.S. market, the FDA requires that clinical trials involving human participants be reviewed and approved by an IRB or an international equivalent. The IRB can reject research based on safety concerns.

In the St. Kitts press release, the Ministry of Health and Social Services said it “will always ensure that all research involving human participants follow international standards which protect the safety and security of persons involved.”

To ensure this happens, an ethics review committee is supposed to vet medical research protocols “in keeping with international best practices.”

The St.Kitts-Nevis Government as well as citizens have been outraged by the revelation of the Herpes Vaccine Trials which operated unknown to any government or local medical officials.

The alleged Trials took place under no approval, oversight or authority of neither the US FDA or St.Kitts Medical Board.

 

Please follow and like us:
0

Leave a comment

Your email address will not be published.


*


Social media & sharing icons powered by UltimatelySocial

Enjoy this blog? Please spread the word :)